Zobrazeno 1 - 10
of 216
pro vyhledávání: ''
Autor:
Debra Nana Yeboa, Laurence D. Rhines, David Boyce-Fappiano, Behrang Amini, Claudio E. Tatsui, Olsi Gjyshi, Andrew J. Bishop, Ahmed Kaseb, Ethan B. Ludmir, Todd A. Pezzi, Amol J. Ghia, Lianchun Xiao, Tina Marie Briere, Jing Li
Publikováno v:
Journal of Neuro-Oncology. 148:327-334
Dose escalation via stereotactic radiation therapy techniques has been necessary for hepatobiliary malignancies in the primary and oligometastatic setting, but such dose escalation is challenging for spine metastases due to spinal cord proximity. Her
Autor:
I-Chun Chen, Ching-Hung Lin, I-Shiow Jan, Yen-Shen Lu, Ann-Lii Cheng, Dwang-Ying Chang, Ho-Min Chen, Tom Wei-Wu Chen
Publikováno v:
Journal of Neuro-Oncology
Introduction Metastatic breast cancer (MBC) with leptomeningeal metastases (LM) has dismal survival. We aim to determine if modern systemic therapy, especially the bevacizumab, cisplatin, and etoposide (BEEP) regimen, is beneficial to MBC LM patients
Autor:
Georg Widhalm, Matthias Preusser, Felix Sahm, Karl Rössler, Adelheid Wöhrer, Anika Simonovska, Barbara Kiesel, Karl Ungersböck, Stefan Oberndorfer, Anna S. Berghoff, Christine Marosi, Julia Furtner, Johannes A. Hainfellner, Maximilian J. Mair
Publikováno v:
Journal of Neuro-Oncology
Introduction Pilocytic astrocytoma (PA) is the most common primary brain neoplasm in children and treated in curative intent with gross total resection (GTR). However, PA is rare in adults, resulting in limited knowledge on the natural clinical cours
Autor:
Stephen Zieminski, Helen A. Shih, William A. Mehan, Henning Willers, Yi Wang, Emily S. Lebow, Melin J. Khandekar, William L. Hwang, Kevin S. Oh, Andrzej Niemierko
Publikováno v:
Journal of Neuro-Oncology. 148:81-88
Cranial irradiation results in cognitive decline, which is hypothesized to be partially attributable to hippocampal injury and stem cell loss. Recent advances allow for targeted reduction of radiation dose to the hippocampi while maintaining adequate
Autor:
Lisa Stefanie Hönikl, Claire Delbridge, Bernhard Meyer, Jens Gempt, Jürgen Schlegel, Friederike Lämmer
Publikováno v:
Journal of Neuro-Oncology
Introduction Glioblastoma multiforme (GBM) is a highly malignant glial tumor, affecting men more often than women. The reason for this gender-specific predominance remains unclear, raising the question whether these effects are subject to hormonal co
Autor:
Bierta E. Barfod, Kyoko Aoyagi, Toru Serizawa, Yoshinori Higuchi, Masaaki Yamamoto, Yasunori Sato, Osamu Nagano, Hidetoshi Kasuya
Publikováno v:
Journal of Neuro-Oncology. 147:177-184
This study aimed to validate whether the recently-proposed prognostic grading system, initial brain metastasis velocity (iBMV), is applicable to breast cancer patients receiving stereotactic radiosurgery (SRS). We focused particularly on whether this
Autor:
Joerg C. Tonn, Rupert Egensperger, Annamaria Biczok, Christine Jungk, Christian Schichor, Christel Herold-Mende, Bogdana Suchorska, Andreas von Deimling
Publikováno v:
Journal of Neuro-Oncology. 145:469-477
For meningiomas, the 2016 revision of the WHO classification introduced brain invasion per se as a sufficient condition to classify as grade II. We analyzed whether meningiomas previously graded as WHO grade I differ in prognosis depending on the pre
Autor:
Oliver Schnell, Christina Hamisch, Elena Jansen, Maximilian I. Ruge, Stefan Grau, Dieter Henrik Heiland, Daniel Ruess, Roland Goldbrunner
Publikováno v:
Journal of Neuro-Oncology. 145:501-507
To provide detailed long-term data after initial observation for patients after histological confirmation of low grade (WHO II) gliomas according to molecular stratification. A series of 110 patients with watchful waiting strategy after initial surge
Publikováno v:
Journal of Neuro-Oncology. 142:263-272
We aim to delineate the clinical characteristics of patients with primary intracranial solitary plasmacytoma (PISPC) and prognostic factors for their outcomes.This study retrospectively reviewed 17 patients with PISPC from our center and an additiona
Publikováno v:
Journal of Neuro-Oncology
Background Tumor treating fields (TTFields) is a non-invasive, antimitotic therapy. In the EF-14 phase 3 trial in newly diagnosed glioblastoma, TTFields plus temozolomide (TTFields/TMZ) improved progression free (PFS) and overall survival (OS) versus